Table 1. Included studies in network meta-analysis.
| Study | Design | Approach | No. | Mean age, yr (± SD) | Gender, men/women | Mean operation time, min (± SD) | Blood loss, mL (± SD) | Mean transfusion (± SD) |
|---|---|---|---|---|---|---|---|---|
| Barrett et al.20 | Prospective RCT | PA | 44 | 63.2 (± 7.7) | 19/25 | 60.5 (± 12.4) | 191 (± 107) | 0.59 pack (± 0.9) |
| DAA | 43 | 61.4 (± 9.2) | 29/14 | 84.3 (± 12.4) | 391 (± 206) | 0.96 pack (± 0.8) | ||
| Bergin et al.8 | Prospective RCT | PA | 28 | 65.1 (± 11.3) | 10/18 | 118 (± 19.4) | 312 (± 138) | |
| DAA | 29 | 68.8 (± 9.1) | 14/15 | 78 (± 17.9) | 360 (± 191) | |||
| Rykov et al.4 | Prospective RCT | PA | 23 | 60.2 (± 8.1) | 11/12 | 62 (± 7) | 273.7 (± 181) | |
| DAA | 23 | 62.8 (± 6.1) | 8/15 | 71 (± 7) | 325.7 (± 99.74) | |||
| Zhao et al.21 | Prospective RCT | PA | 60 | 62.18 (± 14.72) | 26/34 | 65.48 (± 13.32) | 123.84 (± 56.83) | |
| DAA | 60 | 64.88 (± 12.13) | 24/36 | 83.26 (± 6.69) | 165.89 (± 42.6) | |||
| Goosen et al.22 | Prospective RCT | PA | 30 | 62 (± 6.3) | 13/17 | 452 (± 163) | ||
| LA | 30 | 62 (± 6.9) | 16/14 | 532 (± 279) | ||||
| Ji et al.23 | Prospective RCT | PA | 99 | 51 (± 14.5) | 54/45 | 105 (± 25.7) | 331 mL (± 374.3) | |
| LA | 97 | 52 (± 15.1) | 58/39 | 132 (± 37.5) | 323 mL (± 376.8) | |||
| Rosenlund et al.24 | Prospective RCT | PA | 39 | 62 (± 6) | 26/13 | 54 (± 13) | 362 (± 140) | |
| LA | 28 | 60 (± 7) | 26/2 | 60 (± 12) | 363 (± 171) | |||
| D'Arrigo et al.13 | Prospective RCT | DAA | 20 | 64 (± 8) | 12/8 | 121 (± 23.6) | 1,344 (± 710) | |
| LA | 20 | 66.3 (± 10.4) | 14/6 | 102 (± 10.6) | 1,219 (± 786.5) | |||
| LA | 149 | 65 (± 9.8) | 81/68 | 77 (± 15.1) | 1,644 (± 757.7) |
SD = standard deviation, RCT = randomized controlled study, PA = posterolateral approach, DAA = direct anterior approach, LA = anterolateral approach.